Garivulimab Antibody
Garivulimab (BGB-A333) is a humanized anti-PD-L1 monoclonal antibody that blocks the PD-1/PD-L1 pathway to exert antitumor effects. It is utilized in immuno-oncology research for investigating immune checkpoint inhibition in various in vitro cellular assays and in vivo tumor models.
Product Specifications
Target
PD-1/PD-L1
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
7.64 mg/mL
Purity
95.00% (May vary between batches)
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
